Gene Symbol | Gene ID | Gene Info |
---|---|---|
Jun
|
ENSMUSG00000052684.3 | jun proto-oncogene |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_95052117_95052656 | Jun | 164 | 0.810240 | 0.14 | 3.1e-01 | Click! |
chr4_95051873_95052043 | Jun | 264 | 0.618544 | 0.09 | 5.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_20433296_20433507 | 16.29 |
Elmo1 |
engulfment and cell motility 1 |
39325 |
0.14 |
chr1_187910832_187911024 | 14.56 |
Esrrg |
estrogen-related receptor gamma |
86899 |
0.09 |
chr14_47371718_47372034 | 14.04 |
Lgals3 |
lectin, galactose binding, soluble 3 |
1937 |
0.21 |
chr2_170209124_170209516 | 12.97 |
Zfp217 |
zinc finger protein 217 |
61217 |
0.12 |
chr10_89527130_89527354 | 12.75 |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
6343 |
0.22 |
chr19_21106267_21106665 | 12.56 |
4930554I06Rik |
RIKEN cDNA 4930554I06 gene |
1756 |
0.44 |
chr15_102016198_102016386 | 12.49 |
Krt8 |
keratin 8 |
11810 |
0.11 |
chr13_53919976_53920436 | 11.73 |
E130119H09Rik |
RIKEN cDNA E130119H09 gene |
4458 |
0.2 |
chr11_102643877_102644083 | 11.31 |
Gm22920 |
predicted gene, 22920 |
15700 |
0.09 |
chr11_69443424_69443606 | 11.25 |
Dnah2os |
dynein, axonemal, heavy chain 2, opposite strand |
5033 |
0.1 |
chr8_126767539_126767722 | 10.99 |
Gm45805 |
predicted gene 45805 |
9296 |
0.25 |
chr12_16841116_16841293 | 10.78 |
Gm36495 |
predicted gene, 36495 |
9677 |
0.14 |
chr16_87306949_87307599 | 10.66 |
N6amt1 |
N-6 adenine-specific DNA methyltransferase 1 (putative) |
46911 |
0.15 |
chr3_90586966_90587210 | 10.02 |
S100a3 |
S100 calcium binding protein A3 |
136 |
0.89 |
chr10_111576017_111576246 | 9.81 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
18142 |
0.14 |
chr1_91024033_91024229 | 9.80 |
Lrrfip1 |
leucine rich repeat (in FLII) interacting protein 1 |
25352 |
0.15 |
chr5_144317459_144317816 | 9.80 |
Baiap2l1 |
BAI1-associated protein 2-like 1 |
28730 |
0.12 |
chr13_5845211_5845415 | 9.74 |
1700016G22Rik |
RIKEN cDNA 1700016G22 gene |
12248 |
0.16 |
chr15_77397970_77398160 | 9.60 |
Apol7a |
apolipoprotein L 7a |
386 |
0.74 |
chr11_115869511_115869719 | 9.51 |
Myo15b |
myosin XVB |
7901 |
0.1 |
chr6_91488966_91489157 | 9.48 |
Tmem43 |
transmembrane protein 43 |
12461 |
0.1 |
chr4_139179928_139180623 | 9.39 |
Gm16287 |
predicted gene 16287 |
380 |
0.82 |
chr10_121904122_121904479 | 9.36 |
Gm48804 |
predicted gene, 48804 |
72242 |
0.09 |
chr2_35267247_35267474 | 9.35 |
Gsn |
gelsolin |
10911 |
0.14 |
chr18_33292812_33293223 | 9.34 |
Stard4 |
StAR-related lipid transfer (START) domain containing 4 |
79155 |
0.1 |
chr11_86380580_86380731 | 9.16 |
Med13 |
mediator complex subunit 13 |
23053 |
0.16 |
chr5_39762138_39762304 | 9.11 |
Hs3st1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 1 |
6746 |
0.26 |
chr11_16800630_16801057 | 9.08 |
Egfros |
epidermal growth factor receptor, opposite strand |
29859 |
0.17 |
chr13_35395815_35395979 | 8.99 |
Gm48703 |
predicted gene, 48703 |
514 |
0.84 |
chr5_134946861_134947243 | 8.95 |
Cldn4 |
claudin 4 |
118 |
0.91 |
chr18_60605971_60606545 | 8.94 |
Synpo |
synaptopodin |
3847 |
0.19 |
chr13_5769588_5769914 | 8.84 |
Gm35330 |
predicted gene, 35330 |
45241 |
0.14 |
chr14_121435868_121436092 | 8.77 |
Gm33299 |
predicted gene, 33299 |
19782 |
0.17 |
chr11_8579923_8580154 | 8.65 |
Tns3 |
tensin 3 |
917 |
0.73 |
chr15_34254452_34254678 | 8.63 |
Gm18949 |
predicted gene, 18949 |
15264 |
0.15 |
chr6_94241302_94241597 | 8.62 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
41576 |
0.18 |
chr1_182528017_182528239 | 8.58 |
Capn2 |
calpain 2 |
10520 |
0.14 |
chr1_82831958_82832147 | 8.50 |
Gm22396 |
predicted gene, 22396 |
7394 |
0.1 |
chr10_116996297_116996528 | 8.48 |
Best3 |
bestrophin 3 |
10098 |
0.11 |
chr11_83869216_83869522 | 8.47 |
Hnf1b |
HNF1 homeobox B |
16409 |
0.14 |
chr5_32192117_32192300 | 8.46 |
Gm9555 |
predicted gene 9555 |
6711 |
0.16 |
chr6_115462923_115463270 | 8.43 |
Gm44079 |
predicted gene, 44079 |
1894 |
0.33 |
chr13_5803703_5803929 | 8.41 |
Gm26043 |
predicted gene, 26043 |
18042 |
0.19 |
chr14_76817069_76817629 | 8.29 |
Gm48968 |
predicted gene, 48968 |
15472 |
0.18 |
chr2_84619030_84619389 | 8.29 |
Ctnnd1 |
catenin (cadherin associated protein), delta 1 |
6631 |
0.12 |
chr14_63271515_63271859 | 8.27 |
Gata4 |
GATA binding protein 4 |
5 |
0.98 |
chr2_6379891_6380233 | 8.23 |
Usp6nl |
USP6 N-terminal like |
27329 |
0.17 |
chr5_144321752_144322088 | 8.22 |
Baiap2l1 |
BAI1-associated protein 2-like 1 |
33013 |
0.12 |
chr11_63026646_63026985 | 8.18 |
Cdrt4os1 |
CMT1A duplicated region transcript 4, opposite strand 1 |
22681 |
0.15 |
chr14_67158981_67159141 | 8.17 |
Gm30806 |
predicted gene, 30806 |
10527 |
0.2 |
chr19_42017957_42018130 | 8.07 |
Ubtd1 |
ubiquitin domain containing 1 |
894 |
0.43 |
chr13_46043549_46043868 | 8.06 |
Gm45949 |
predicted gene, 45949 |
16889 |
0.23 |
chr4_8218106_8218289 | 8.04 |
Gm25355 |
predicted gene, 25355 |
17385 |
0.2 |
chr3_96093653_96093807 | 8.02 |
Gm43554 |
predicted gene 43554 |
6859 |
0.1 |
chr2_132613669_132613843 | 7.99 |
AU019990 |
expressed sequence AU019990 |
15561 |
0.14 |
chr6_50390261_50390625 | 7.97 |
Osbpl3 |
oxysterol binding protein-like 3 |
6707 |
0.26 |
chr7_110288357_110288545 | 7.97 |
Gm45515 |
predicted gene 45515 |
6924 |
0.18 |
chr13_30109091_30109492 | 7.94 |
Gm11367 |
predicted gene 11367 |
3183 |
0.2 |
chr9_70318732_70318904 | 7.90 |
Mir5626 |
microRNA 5626 |
86935 |
0.07 |
chr15_59759585_59759917 | 7.89 |
Gm19510 |
predicted gene, 19510 |
35208 |
0.19 |
chr4_140665864_140666114 | 7.88 |
Arhgef10l |
Rho guanine nucleotide exchange factor (GEF) 10-like |
23 |
0.97 |
chr5_35739993_35740232 | 7.81 |
Sh3tc1 |
SH3 domain and tetratricopeptide repeats 1 |
125 |
0.96 |
chr11_51916637_51916961 | 7.73 |
Gm39822 |
predicted gene, 39822 |
17833 |
0.14 |
chr18_32153114_32153528 | 7.70 |
Gm26717 |
predicted gene, 26717 |
155 |
0.93 |
chr18_14230612_14230777 | 7.69 |
8430422H06Rik |
RIKEN cDNA 8430422H06 gene |
1615 |
0.48 |
chr11_101056940_101057327 | 7.68 |
Naglu |
alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB) |
12879 |
0.08 |
chr12_111353338_111354089 | 7.65 |
Cdc42bpb |
CDC42 binding protein kinase beta |
23906 |
0.13 |
chr8_116071511_116071815 | 7.64 |
Gm45733 |
predicted gene 45733 |
99592 |
0.08 |
chr5_29083308_29083648 | 7.63 |
Rnf32 |
ring finger protein 32 |
112514 |
0.06 |
chr16_78260390_78260785 | 7.63 |
E330011O21Rik |
RIKEN cDNA E330011O21 gene |
5365 |
0.17 |
chr15_81845688_81846041 | 7.63 |
Gm8444 |
predicted gene 8444 |
2151 |
0.16 |
chr1_60609474_60609750 | 7.59 |
Gm23762 |
predicted gene, 23762 |
4191 |
0.16 |
chr13_73803834_73804271 | 7.57 |
Slc12a7 |
solute carrier family 12, member 7 |
557 |
0.73 |
chr11_59459005_59459317 | 7.55 |
Snap47 |
synaptosomal-associated protein, 47 |
7975 |
0.1 |
chr7_131012005_131012156 | 7.52 |
Dmbt1 |
deleted in malignant brain tumors 1 |
19966 |
0.17 |
chr8_8602663_8602994 | 7.51 |
Gm45075 |
predicted gene 45075 |
9436 |
0.12 |
chr7_45680019_45680234 | 7.51 |
Ntn5 |
netrin 5 |
3896 |
0.07 |
chr2_61138998_61139217 | 7.48 |
Gm13581 |
predicted gene 13581 |
85685 |
0.09 |
chr2_59670440_59670670 | 7.48 |
Tanc1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
23744 |
0.24 |
chr6_50254998_50255157 | 7.48 |
Gsdme |
gasdermin E |
6670 |
0.24 |
chr9_117134110_117134303 | 7.48 |
Gm20397 |
predicted gene 20397 |
68679 |
0.11 |
chr12_59198910_59199071 | 7.46 |
Fbxo33 |
F-box protein 33 |
5446 |
0.16 |
chr6_70872116_70872474 | 7.45 |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
6266 |
0.15 |
chr8_93229095_93229265 | 7.42 |
Ces1e |
carboxylesterase 1E |
438 |
0.77 |
chr14_20973860_20974094 | 7.40 |
Vcl |
vinculin |
44579 |
0.14 |
chr1_39105614_39105791 | 7.39 |
Gm37091 |
predicted gene, 37091 |
22364 |
0.17 |
chr11_19979434_19979792 | 7.39 |
Spred2 |
sprouty-related EVH1 domain containing 2 |
25043 |
0.23 |
chr5_144290139_144290327 | 7.37 |
Baiap2l1 |
BAI1-associated protein 2-like 1 |
1326 |
0.35 |
chr15_102017591_102018334 | 7.36 |
Krt18 |
keratin 18 |
10218 |
0.11 |
chr15_83345013_83345231 | 7.33 |
Arfgap3 |
ADP-ribosylation factor GTPase activating protein 3 |
5052 |
0.17 |
chr14_62825661_62825815 | 7.33 |
Gm47505 |
predicted gene, 47505 |
6895 |
0.13 |
chr9_118512679_118512989 | 7.32 |
Golga4 |
golgi autoantigen, golgin subfamily a, 4 |
1346 |
0.37 |
chr6_72293404_72293624 | 7.32 |
Sftpb |
surfactant associated protein B |
11096 |
0.13 |
chr5_146779886_146780047 | 7.29 |
Usp12 |
ubiquitin specific peptidase 12 |
15040 |
0.14 |
chr7_75427423_75427605 | 7.25 |
Gm44962 |
predicted gene 44962 |
6379 |
0.19 |
chr3_105895398_105895606 | 7.23 |
Adora3 |
adenosine A3 receptor |
8919 |
0.12 |
chr1_192061751_192061962 | 7.23 |
Traf5 |
TNF receptor-associated factor 5 |
2694 |
0.19 |
chr15_37202053_37202303 | 7.21 |
Gm8664 |
predicted gene 8664 |
19477 |
0.13 |
chr5_32035824_32035996 | 7.20 |
Babam2 |
BRISC and BRCA1 A complex member 2 |
10068 |
0.19 |
chr5_115493012_115493378 | 7.17 |
Gm13836 |
predicted gene 13836 |
740 |
0.4 |
chr3_101709597_101709951 | 7.14 |
Gm43135 |
predicted gene 43135 |
17985 |
0.19 |
chr7_99215294_99215768 | 7.09 |
Gm45012 |
predicted gene 45012 |
13165 |
0.12 |
chr18_36416581_36416796 | 7.06 |
Pfdn1 |
prefoldin 1 |
34556 |
0.13 |
chr16_78318022_78318316 | 7.05 |
Cxadr |
coxsackie virus and adenovirus receptor |
7038 |
0.16 |
chr17_70746787_70747024 | 7.04 |
5031415H12Rik |
RIKEN cDNA 5031415H12 gene |
8677 |
0.19 |
chr4_123422789_123423138 | 7.01 |
Macf1 |
microtubule-actin crosslinking factor 1 |
10735 |
0.17 |
chr2_11429503_11430010 | 7.00 |
Gm13296 |
predicted gene 13296 |
9532 |
0.12 |
chr8_23934635_23934786 | 7.00 |
Zmat4 |
zinc finger, matrin type 4 |
5657 |
0.32 |
chr6_99931696_99931882 | 6.99 |
Gm44442 |
predicted gene, 44442 |
240 |
0.93 |
chr3_85880763_85880991 | 6.99 |
Gm37240 |
predicted gene, 37240 |
6491 |
0.11 |
chr11_50212819_50213300 | 6.96 |
Mgat4b |
mannoside acetylglucosaminyltransferase 4, isoenzyme B |
2169 |
0.17 |
chr13_103978322_103978497 | 6.94 |
Gm47851 |
predicted gene, 47851 |
79 |
0.97 |
chr3_28721874_28722084 | 6.93 |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
462 |
0.78 |
chr13_31567759_31567922 | 6.87 |
Gm11377 |
predicted gene 11377 |
3091 |
0.17 |
chr1_21014556_21014739 | 6.86 |
Tram2 |
translocating chain-associating membrane protein 2 |
29009 |
0.14 |
chr19_55542605_55542756 | 6.84 |
Vti1a |
vesicle transport through interaction with t-SNAREs 1A |
161666 |
0.04 |
chr13_73290325_73290562 | 6.83 |
Gm48000 |
predicted gene, 48000 |
17213 |
0.13 |
chr7_135509348_135509534 | 6.77 |
Clrn3 |
clarin 3 |
19213 |
0.15 |
chr2_159168641_159168822 | 6.77 |
Gm25090 |
predicted gene, 25090 |
29370 |
0.23 |
chr6_24707199_24707385 | 6.77 |
Hyal6 |
hyaluronoglucosaminidase 6 |
25953 |
0.14 |
chr11_93987786_93987965 | 6.77 |
Spag9 |
sperm associated antigen 9 |
8216 |
0.15 |
chr18_20457276_20457436 | 6.75 |
Dsg4 |
desmoglein 4 |
21181 |
0.17 |
chr7_29469550_29470116 | 6.73 |
Sipa1l3 |
signal-induced proliferation-associated 1 like 3 |
35619 |
0.12 |
chr16_95831584_95831933 | 6.71 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
14012 |
0.17 |
chr11_53308418_53308652 | 6.67 |
Hspa4 |
heat shock protein 4 |
8078 |
0.14 |
chr8_104384125_104384334 | 6.66 |
Cmtm4 |
CKLF-like MARVEL transmembrane domain containing 4 |
11578 |
0.09 |
chr15_59823427_59823774 | 6.65 |
Gm19510 |
predicted gene, 19510 |
28641 |
0.21 |
chr5_150466046_150466511 | 6.64 |
Fry |
FRY microtubule binding protein |
5632 |
0.12 |
chr14_55795859_55796198 | 6.63 |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
7163 |
0.08 |
chr6_43292547_43292721 | 6.61 |
Arhgef5 |
Rho guanine nucleotide exchange factor (GEF) 5 |
9752 |
0.12 |
chr13_51853368_51853543 | 6.61 |
Gadd45g |
growth arrest and DNA-damage-inducible 45 gamma |
6711 |
0.25 |
chr13_60662673_60662836 | 6.60 |
Gm48583 |
predicted gene, 48583 |
20964 |
0.15 |
chr1_184781740_184782518 | 6.60 |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
26724 |
0.12 |
chr19_38025442_38025647 | 6.55 |
Myof |
myoferlin |
17807 |
0.14 |
chr15_73535748_73535932 | 6.54 |
Dennd3 |
DENN/MADD domain containing 3 |
11706 |
0.18 |
chr17_26549572_26549759 | 6.53 |
Gm8225 |
predicted gene 8225 |
6905 |
0.11 |
chr4_43728671_43728843 | 6.53 |
Spaar |
small regulatory polypeptide of amino acid response |
1277 |
0.21 |
chr17_31305321_31305519 | 6.53 |
Slc37a1 |
solute carrier family 37 (glycerol-3-phosphate transporter), member 1 |
123 |
0.95 |
chr1_125389870_125390183 | 6.51 |
Actr3 |
ARP3 actin-related protein 3 |
7586 |
0.28 |
chr16_32859311_32859478 | 6.51 |
Rubcn |
RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein |
8944 |
0.14 |
chr11_94346751_94346915 | 6.50 |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
4353 |
0.17 |
chr3_97076076_97076280 | 6.50 |
4930573H18Rik |
RIKEN cDNA 4930573H18 gene |
16607 |
0.15 |
chr9_96650075_96650243 | 6.50 |
Rasa2 |
RAS p21 protein activator 2 |
18542 |
0.16 |
chr1_90690831_90691200 | 6.49 |
Gm9991 |
predicted gene 9991 |
15854 |
0.22 |
chr1_156468029_156468228 | 6.46 |
Soat1 |
sterol O-acyltransferase 1 |
1324 |
0.39 |
chr9_48707570_48707723 | 6.41 |
Nnmt |
nicotinamide N-methyltransferase |
102493 |
0.06 |
chr3_94987677_94987869 | 6.39 |
A730011C13Rik |
RIKEN cDNA A730011C13 gene |
9223 |
0.08 |
chr3_52897929_52898080 | 6.39 |
Gm20750 |
predicted gene, 20750 |
29662 |
0.16 |
chr6_5442722_5443006 | 6.39 |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
52437 |
0.14 |
chr11_51874376_51874559 | 6.37 |
Jade2 |
jade family PHD finger 2 |
16814 |
0.15 |
chr7_141164926_141165096 | 6.37 |
Rnh1 |
ribonuclease/angiogenin inhibitor 1 |
3117 |
0.1 |
chr9_96135028_96135188 | 6.36 |
Gk5 |
glycerol kinase 5 (putative) |
10888 |
0.19 |
chr9_57968998_57969161 | 6.35 |
Gm17322 |
predicted gene, 17322 |
28962 |
0.11 |
chr19_17140497_17140657 | 6.35 |
Prune2 |
prune homolog 2 |
1838 |
0.45 |
chr1_74438143_74438336 | 6.33 |
Vil1 |
villin 1 |
14553 |
0.11 |
chr17_65617138_65617298 | 6.33 |
Vapa |
vesicle-associated membrane protein, associated protein A |
3663 |
0.2 |
chr9_70275267_70275431 | 6.33 |
Myo1e |
myosin IE |
67981 |
0.1 |
chr1_58304437_58304639 | 6.31 |
Gm15759 |
predicted gene 15759 |
11118 |
0.17 |
chr9_40776517_40776669 | 6.30 |
Clmp |
CXADR-like membrane protein |
2499 |
0.14 |
chr7_80762415_80762566 | 6.29 |
Gm44649 |
predicted gene 44649 |
10645 |
0.17 |
chr6_113031386_113031543 | 6.27 |
Gm23244 |
predicted gene, 23244 |
4470 |
0.12 |
chr7_25430237_25430677 | 6.26 |
Gm20949 |
predicted gene, 20949 |
7665 |
0.1 |
chr11_103382021_103382275 | 6.26 |
Plekhm1 |
pleckstrin homology domain containing, family M (with RUN domain) member 1 |
12620 |
0.12 |
chr11_76916634_76916803 | 6.25 |
Blmh |
bleomycin hydrolase |
8091 |
0.17 |
chr6_49656665_49656852 | 6.25 |
Gm44219 |
predicted gene, 44219 |
70765 |
0.11 |
chr2_131902867_131903054 | 6.25 |
Lamr1-ps1 |
laminin receptor 1 (ribosomal protein SA), pseudogene 1 |
1126 |
0.38 |
chr16_18639472_18639643 | 6.25 |
Septin5 |
septin 5 |
9603 |
0.12 |
chr7_65469748_65469948 | 6.24 |
Gm44792 |
predicted gene 44792 |
11373 |
0.21 |
chr14_79515518_79515689 | 6.23 |
Elf1 |
E74-like factor 1 |
71 |
0.97 |
chr12_103457142_103457402 | 6.23 |
Ifi27l2b |
interferon, alpha-inducible protein 27 like 2B |
49 |
0.95 |
chr9_117571354_117571507 | 6.23 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
58483 |
0.16 |
chr5_131814531_131814709 | 6.23 |
4930563F08Rik |
RIKEN cDNA 4930563F08 gene |
65649 |
0.08 |
chr8_115561211_115561418 | 6.22 |
4930488N15Rik |
RIKEN cDNA 4930488N15 gene |
24078 |
0.21 |
chr10_41565234_41565410 | 6.21 |
5730435O14Rik |
RIKEN cDNA 5730435O14 gene |
2694 |
0.19 |
chr6_18271101_18271252 | 6.19 |
Cftr |
cystic fibrosis transmembrane conductance regulator |
15952 |
0.16 |
chr1_135183508_135183704 | 6.19 |
Gpr37l1 |
G protein-coupled receptor 37-like 1 |
15925 |
0.1 |
chr8_31521037_31521219 | 6.18 |
Gm45303 |
predicted gene 45303 |
29152 |
0.21 |
chr6_87868882_87869197 | 6.17 |
Gm44064 |
predicted gene, 44064 |
17830 |
0.07 |
chr10_94480853_94481004 | 6.17 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
33929 |
0.17 |
chr17_24000607_24000805 | 6.17 |
Prss22 |
protease, serine 22 |
2606 |
0.11 |
chr9_116223471_116223643 | 6.16 |
Gm31410 |
predicted gene, 31410 |
4755 |
0.21 |
chr11_60935403_60935625 | 6.16 |
Map2k3 |
mitogen-activated protein kinase kinase 3 |
3448 |
0.16 |
chr9_77482447_77482603 | 6.16 |
Lrrc1 |
leucine rich repeat containing 1 |
40034 |
0.13 |
chr1_87551184_87551382 | 6.14 |
Gm6153 |
predicted gene 6153 |
6591 |
0.15 |
chr16_24313654_24313828 | 6.14 |
AC169509.1 |
BMP2 inducible kinase (Bmp2k) pseudogene |
23905 |
0.17 |
chr12_84400800_84400985 | 6.12 |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
7 |
0.96 |
chr18_42053512_42053682 | 6.12 |
Sh3rf2 |
SH3 domain containing ring finger 2 |
70 |
0.98 |
chr6_113434771_113434951 | 6.12 |
Cidec |
cell death-inducing DFFA-like effector c |
97 |
0.91 |
chr5_100861897_100862062 | 6.11 |
4930458D05Rik |
RIKEN cDNA 4930458D05 gene |
14812 |
0.1 |
chr7_132901294_132901559 | 6.11 |
Gm45502 |
predicted gene 45502 |
9663 |
0.13 |
chrX_145497564_145497742 | 6.09 |
Amot |
angiomotin |
7491 |
0.28 |
chr17_46004292_46004515 | 6.08 |
Vegfa |
vascular endothelial growth factor A |
16969 |
0.16 |
chr10_77206640_77207012 | 6.07 |
Col18a1 |
collagen, type XVIII, alpha 1 |
40278 |
0.12 |
chr6_97341674_97341893 | 6.07 |
Frmd4b |
FERM domain containing 4B |
12394 |
0.23 |
chr11_100387947_100388277 | 6.07 |
Jup |
junction plakoglobin |
1342 |
0.22 |
chr11_120554974_120555184 | 6.06 |
Ppp1r27 |
protein phosphatase 1, regulatory subunit 27 |
3947 |
0.07 |
chr18_36384141_36384324 | 6.06 |
Cystm1 |
cysteine-rich transmembrane module containing 1 |
18451 |
0.18 |
chr7_112252122_112252398 | 6.05 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
19039 |
0.26 |
chr16_87348252_87348433 | 6.04 |
N6amt1 |
N-6 adenine-specific DNA methyltransferase 1 (putative) |
5843 |
0.24 |
chr7_145222028_145222198 | 6.03 |
Smim38 |
small integral membrane protein 38 |
13994 |
0.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 16.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
3.3 | 9.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
2.7 | 2.7 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
2.6 | 7.7 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
2.4 | 7.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.3 | 7.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
2.3 | 6.9 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
2.2 | 6.7 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
1.9 | 7.7 | GO:0003164 | His-Purkinje system development(GO:0003164) |
1.8 | 5.5 | GO:1902896 | terminal web assembly(GO:1902896) |
1.7 | 8.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.7 | 3.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.6 | 4.7 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
1.6 | 6.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.5 | 4.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.5 | 7.3 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.5 | 5.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.4 | 11.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.4 | 2.8 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.4 | 4.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.3 | 4.0 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.3 | 3.9 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.3 | 2.6 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.3 | 3.9 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
1.3 | 3.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.3 | 3.8 | GO:0048320 | axial mesoderm formation(GO:0048320) |
1.3 | 1.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.3 | 11.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.3 | 8.9 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.3 | 3.8 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.2 | 4.9 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.2 | 4.9 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.2 | 8.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.2 | 3.6 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
1.2 | 6.1 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
1.2 | 3.6 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
1.2 | 13.3 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
1.2 | 4.8 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.2 | 2.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.2 | 5.8 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.1 | 3.4 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.1 | 4.5 | GO:0015793 | glycerol transport(GO:0015793) |
1.1 | 7.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.1 | 3.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.1 | 2.2 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.1 | 2.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.1 | 5.4 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.1 | 3.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.1 | 4.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.0 | 4.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.0 | 2.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.0 | 2.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.0 | 4.0 | GO:0032532 | regulation of microvillus length(GO:0032532) |
1.0 | 1.0 | GO:0060347 | heart trabecula formation(GO:0060347) |
1.0 | 6.9 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.0 | 1.0 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
1.0 | 3.9 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
1.0 | 4.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.9 | 3.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.9 | 4.6 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.9 | 8.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.9 | 2.7 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.9 | 5.5 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.9 | 3.6 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.9 | 7.3 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.9 | 2.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.9 | 2.7 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.9 | 0.9 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.9 | 7.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.9 | 2.7 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.9 | 8.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.9 | 1.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.9 | 2.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.9 | 7.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.9 | 1.7 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.9 | 7.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.9 | 4.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.9 | 5.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.8 | 7.6 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.8 | 2.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.8 | 2.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.8 | 2.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.8 | 3.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.8 | 1.6 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.8 | 1.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.8 | 1.6 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.8 | 1.6 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.8 | 0.8 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.8 | 2.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.8 | 2.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.8 | 1.6 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.8 | 0.8 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.8 | 5.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.8 | 3.8 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.8 | 7.7 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.8 | 3.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.7 | 3.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.7 | 3.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.7 | 2.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.7 | 2.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.7 | 2.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.7 | 2.9 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.7 | 3.7 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.7 | 2.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.7 | 3.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.7 | 5.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.7 | 2.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.7 | 0.7 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.7 | 6.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.7 | 0.7 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.7 | 12.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.7 | 4.3 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.7 | 7.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.7 | 2.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.7 | 2.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.7 | 2.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 2.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.7 | 2.1 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.7 | 4.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.7 | 4.8 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.7 | 4.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.7 | 2.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.7 | 2.0 | GO:0032439 | endosome localization(GO:0032439) |
0.7 | 1.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.7 | 2.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.7 | 4.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.7 | 2.0 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.7 | 0.7 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.7 | 2.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.7 | 2.6 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.7 | 1.3 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.6 | 1.9 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.6 | 1.9 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.6 | 3.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.6 | 4.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.6 | 1.3 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.6 | 1.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.6 | 1.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.6 | 5.7 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.6 | 1.3 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.6 | 1.9 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.6 | 1.2 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.6 | 0.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.6 | 1.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.6 | 1.9 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.6 | 0.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.6 | 1.9 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.6 | 3.7 | GO:0051775 | response to redox state(GO:0051775) |
0.6 | 1.2 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.6 | 6.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.6 | 0.6 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.6 | 0.6 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.6 | 4.3 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.6 | 1.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.6 | 1.8 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.6 | 0.6 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.6 | 9.5 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.6 | 8.9 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.6 | 1.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.6 | 1.8 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.6 | 2.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.6 | 1.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.6 | 0.6 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.6 | 1.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.6 | 1.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.6 | 2.3 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.6 | 1.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.6 | 2.3 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.6 | 5.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.6 | 2.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.6 | 1.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.6 | 2.8 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.6 | 1.7 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.6 | 5.1 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.6 | 1.7 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.6 | 0.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.6 | 1.7 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.6 | 2.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 2.7 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.5 | 4.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.5 | 4.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.5 | 2.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.5 | 1.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.5 | 2.7 | GO:0009249 | protein lipoylation(GO:0009249) |
0.5 | 2.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.5 | 2.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.5 | 3.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.5 | 11.8 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.5 | 5.9 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.5 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.5 | 1.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.5 | 3.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.5 | 1.6 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.5 | 1.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.5 | 1.6 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.5 | 1.6 | GO:1903416 | response to glycoside(GO:1903416) |
0.5 | 1.6 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.5 | 1.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.5 | 5.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.5 | 1.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.5 | 2.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.5 | 1.0 | GO:0002159 | desmosome assembly(GO:0002159) |
0.5 | 1.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.5 | 4.6 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.5 | 0.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 1.5 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.5 | 2.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.5 | 0.5 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.5 | 2.0 | GO:0009136 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.5 | 1.5 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.5 | 0.5 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.5 | 1.0 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.5 | 1.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.5 | 1.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.5 | 0.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.5 | 1.5 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.5 | 1.5 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.5 | 1.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.5 | 1.5 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.5 | 0.5 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.5 | 1.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.5 | 2.4 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.5 | 1.9 | GO:0048143 | astrocyte activation(GO:0048143) |
0.5 | 1.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.5 | 1.4 | GO:0015744 | succinate transport(GO:0015744) |
0.5 | 0.5 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.5 | 1.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.5 | 0.5 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.5 | 0.9 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.5 | 1.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.5 | 1.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.5 | 0.5 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.5 | 0.5 | GO:0002434 | immune complex clearance(GO:0002434) |
0.5 | 1.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 4.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.5 | 1.8 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.5 | 1.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.5 | 1.4 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.5 | 1.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.5 | 1.4 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.5 | 0.5 | GO:0050904 | diapedesis(GO:0050904) |
0.5 | 2.7 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.5 | 0.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.5 | 0.9 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.5 | 1.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 1.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.5 | 1.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.5 | 1.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.5 | 2.3 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.5 | 0.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.5 | 1.8 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.4 | 0.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.4 | 2.7 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.4 | 0.9 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.4 | 0.9 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.4 | 2.2 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 1.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 0.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 1.8 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.4 | 1.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 2.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 1.3 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.4 | 4.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.4 | 1.7 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.4 | 0.9 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.4 | 1.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 2.2 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.4 | 0.4 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.4 | 0.4 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.4 | 2.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 0.9 | GO:0097531 | mast cell migration(GO:0097531) |
0.4 | 2.6 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.4 | 0.4 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.4 | 0.4 | GO:1903596 | regulation of gap junction assembly(GO:1903596) positive regulation of gap junction assembly(GO:1903598) |
0.4 | 0.4 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.4 | 1.3 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 1.3 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.4 | 4.6 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.4 | 2.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.4 | 0.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 0.4 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.4 | 2.1 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.4 | 1.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.4 | 2.1 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.4 | 0.8 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.4 | 2.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.4 | 1.3 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.4 | 1.3 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.4 | 2.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.4 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.4 | 0.8 | GO:1904970 | brush border assembly(GO:1904970) |
0.4 | 1.2 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.4 | 0.4 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.4 | 1.7 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.4 | 0.8 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.4 | 10.7 | GO:0045214 | sarcomere organization(GO:0045214) |
0.4 | 0.8 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.4 | 1.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.4 | 0.8 | GO:0060068 | vagina development(GO:0060068) |
0.4 | 1.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 2.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 2.5 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.4 | 5.7 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.4 | 0.4 | GO:0070375 | ventricular cardiac myofibril assembly(GO:0055005) ERK5 cascade(GO:0070375) |
0.4 | 5.7 | GO:0034389 | lipid particle organization(GO:0034389) |
0.4 | 3.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.4 | 0.4 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.4 | 0.8 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.4 | 1.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.4 | 0.8 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.4 | 4.8 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.4 | 13.1 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.4 | 2.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.4 | 0.4 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.4 | 4.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 2.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.4 | 2.0 | GO:0042737 | drug catabolic process(GO:0042737) |
0.4 | 0.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.4 | 1.6 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.4 | 0.4 | GO:0060594 | mammary gland specification(GO:0060594) |
0.4 | 1.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.4 | 3.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 0.8 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.4 | 0.8 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.4 | 2.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.4 | 1.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.4 | 0.4 | GO:0060066 | oviduct development(GO:0060066) |
0.4 | 0.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.4 | 0.4 | GO:0001893 | maternal placenta development(GO:0001893) |
0.4 | 1.9 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 5.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.4 | 1.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 0.8 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.4 | 1.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.4 | 0.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 1.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.4 | 0.7 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.4 | 2.6 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.4 | 0.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.4 | 0.4 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) endothelial tube morphogenesis(GO:0061154) |
0.4 | 3.0 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.4 | 0.4 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.4 | 2.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 1.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 0.7 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.4 | 0.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.4 | 1.4 | GO:0042637 | catagen(GO:0042637) |
0.4 | 1.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.4 | 1.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 2.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 1.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.4 | 0.7 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.4 | 0.4 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.4 | 3.6 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.4 | 1.8 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.4 | 0.7 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.4 | 2.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.4 | 0.4 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.4 | 0.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.4 | 0.4 | GO:0033483 | gas homeostasis(GO:0033483) |
0.4 | 0.4 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 2.8 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.4 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 3.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 0.7 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.4 | 1.4 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.3 | 0.7 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.3 | 1.4 | GO:0061042 | vascular wound healing(GO:0061042) |
0.3 | 1.0 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 1.0 | GO:1901888 | regulation of cell junction assembly(GO:1901888) |
0.3 | 1.0 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 3.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 1.4 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 0.7 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.3 | 0.3 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.3 | 3.8 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.3 | 0.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 1.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.3 | 2.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.3 | 1.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 0.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.3 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.3 | 0.3 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.3 | 3.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.3 | 1.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.3 | 2.4 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.3 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 0.3 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.3 | 2.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.3 | 1.7 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.3 | 1.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 1.7 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 2.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.3 | 2.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 1.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 1.6 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.3 | 0.3 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) |
0.3 | 3.8 | GO:0014850 | response to muscle activity(GO:0014850) |
0.3 | 0.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.3 | 0.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 1.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 1.3 | GO:0042033 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
0.3 | 0.9 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.3 | 0.6 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.3 | 1.9 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.3 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 1.3 | GO:0009597 | detection of virus(GO:0009597) |
0.3 | 0.9 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.3 | 1.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 5.6 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.3 | 6.6 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.3 | 0.6 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.3 | 0.9 | GO:0010226 | response to lithium ion(GO:0010226) |
0.3 | 0.3 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.3 | 0.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 1.5 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.3 | 0.6 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 0.9 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.3 | 1.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 0.6 | GO:0007494 | midgut development(GO:0007494) |
0.3 | 0.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.6 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.3 | 0.9 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 1.5 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.3 | 0.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 1.5 | GO:0044851 | hair cycle phase(GO:0044851) |
0.3 | 1.2 | GO:0046959 | habituation(GO:0046959) |
0.3 | 3.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.3 | 0.6 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.3 | 2.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.3 | 0.3 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.3 | 0.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.3 | 0.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 0.6 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.3 | 1.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 0.6 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.3 | 3.0 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 1.2 | GO:0007398 | ectoderm development(GO:0007398) |
0.3 | 0.6 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 0.6 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.3 | 0.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 0.6 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.3 | 0.6 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.3 | 2.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.3 | 0.6 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.3 | 0.3 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.3 | 1.5 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.3 | 0.3 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.3 | 6.1 | GO:0042246 | tissue regeneration(GO:0042246) |
0.3 | 3.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.3 | 0.9 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.3 | 0.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 1.4 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.3 | 0.6 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.3 | 0.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 2.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.3 | 0.9 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.3 | 2.9 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 2.3 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 0.9 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.3 | 2.9 | GO:0097320 | membrane tubulation(GO:0097320) |
0.3 | 5.4 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.3 | 0.3 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.3 | 0.6 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.3 | 1.4 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.3 | 1.4 | GO:0032782 | bile acid secretion(GO:0032782) |
0.3 | 1.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.3 | 0.6 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.3 | 0.3 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 2.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 1.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 2.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 0.8 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.3 | 0.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.3 | 0.8 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 11.0 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.3 | 0.6 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.3 | 0.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.3 | 0.6 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 4.8 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.3 | 7.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 0.8 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.3 | 0.3 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.3 | 1.7 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.3 | 0.3 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.3 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.3 | 0.3 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.3 | 0.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.3 | 1.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.3 | 0.3 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.3 | 0.3 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.3 | 1.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 2.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.3 | 0.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.3 | 0.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 0.3 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.3 | 3.0 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.3 | 0.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 1.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.3 | 0.3 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.3 | 1.3 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.3 | 0.5 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 3.5 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.3 | 0.3 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.3 | 0.3 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.3 | 1.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 0.8 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.3 | 0.8 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 1.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 0.8 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.3 | 0.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 0.8 | GO:0015791 | polyol transport(GO:0015791) |
0.3 | 0.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.8 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.3 | 1.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.3 | 0.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 0.8 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 0.8 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 0.5 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.3 | 0.5 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.3 | 0.5 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.3 | 0.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 1.0 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 0.5 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.3 | 1.0 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.3 | 3.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.3 | 0.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 2.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 2.3 | GO:0070527 | platelet aggregation(GO:0070527) |
0.3 | 1.8 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.3 | 2.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 1.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.3 | 1.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.3 | 1.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.3 | 0.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 0.3 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.3 | 0.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 1.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 0.8 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.3 | 4.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.3 | 2.8 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.3 | 1.0 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 1.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.3 | 1.8 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.3 | 0.3 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.3 | 0.3 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.3 | 4.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.3 | 0.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.5 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 1.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.5 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 2.0 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.2 | 0.2 | GO:1901838 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.2 | 0.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 1.0 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.2 | 1.7 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 1.0 | GO:0018214 | protein carboxylation(GO:0018214) |
0.2 | 1.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 3.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 0.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.2 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.2 | 1.2 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 1.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 6.2 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.2 | 1.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.5 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.2 | 1.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 3.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 1.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.7 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.2 | 1.6 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 1.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 0.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 0.9 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.2 | 1.4 | GO:0035878 | nail development(GO:0035878) |
0.2 | 1.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.7 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
0.2 | 0.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 1.2 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.2 | 0.2 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.2 | 1.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 3.0 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.2 | 0.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.2 | 0.5 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 2.7 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.2 | 0.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.7 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.2 | 0.9 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 2.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 0.4 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.2 | 0.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.2 | 2.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 0.4 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) |
0.2 | 0.4 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.2 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.9 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 1.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.2 | 0.7 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.2 | 0.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.6 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.2 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.9 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.6 | GO:0046689 | response to mercury ion(GO:0046689) |
0.2 | 2.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.6 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.6 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 0.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.2 | 1.3 | GO:0000338 | protein deneddylation(GO:0000338) |
0.2 | 0.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 0.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.2 | 0.2 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.2 | 0.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.2 | 0.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.2 | 1.7 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.2 | 1.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.6 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 1.4 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.2 | 1.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 1.0 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 1.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.2 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.2 | 1.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 1.0 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 0.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 1.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.2 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.2 | 0.8 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 1.0 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.2 | 0.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.2 | 0.2 | GO:0045986 | negative regulation of muscle contraction(GO:0045932) negative regulation of smooth muscle contraction(GO:0045986) |
0.2 | 1.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 0.4 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
0.2 | 0.2 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.2 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 0.2 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.2 | 0.4 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.2 | 0.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 1.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 3.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.2 | 2.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.4 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 1.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 0.6 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.2 | 0.8 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.6 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 1.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 1.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.2 | 1.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 0.8 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 2.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.8 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
0.2 | 0.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 2.7 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.2 | 4.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 0.4 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.2 | 0.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.2 | 4.4 | GO:0043489 | RNA stabilization(GO:0043489) |
0.2 | 0.6 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 0.8 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 0.4 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 0.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.2 | 0.8 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.4 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.4 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.2 | 2.8 | GO:0034340 | response to type I interferon(GO:0034340) |
0.2 | 0.6 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.2 | 0.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 0.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 1.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.6 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 1.1 | GO:0055023 | positive regulation of cardiac muscle tissue growth(GO:0055023) |
0.2 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.4 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 0.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.4 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.2 | 0.4 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 1.8 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.2 | 0.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 0.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.2 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.2 | 0.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 1.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.4 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.2 | 0.7 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 1.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 0.5 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 0.4 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.2 | 0.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.9 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 1.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 0.2 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.2 | 0.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.4 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 1.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.2 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.2 | 0.7 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.2 | 0.7 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.2 | 1.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 0.3 | GO:0045991 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite regulation of transcription(GO:0045990) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
0.2 | 0.3 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.2 | 0.2 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 0.5 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.2 | 0.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 1.7 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 0.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.7 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.3 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.2 | 0.5 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 1.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 0.5 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 2.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.7 | GO:0033574 | response to testosterone(GO:0033574) |
0.2 | 1.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 0.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 1.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 1.2 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 1.0 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.2 | 0.5 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.2 | 0.3 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.2 | 0.3 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.2 | 0.7 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 1.0 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 1.0 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.2 | GO:0046325 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.2 | 1.5 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.2 | 0.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.5 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.2 | 1.0 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.2 | 3.0 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 3.5 | GO:0015914 | phospholipid transport(GO:0015914) |
0.2 | 0.2 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.2 | 0.3 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.2 | 0.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 0.6 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 0.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.2 | GO:0021586 | pons maturation(GO:0021586) |
0.2 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 5.5 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 0.2 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.2 | 3.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.3 | GO:0048241 | epinephrine transport(GO:0048241) |
0.2 | 0.6 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.6 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.2 | 1.4 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.2 | 0.8 | GO:0031100 | organ regeneration(GO:0031100) |
0.2 | 0.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.3 | GO:0043586 | tongue development(GO:0043586) |
0.2 | 0.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 0.6 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.2 | 0.5 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.2 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.8 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.2 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 2.0 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.2 | 0.6 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.2 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.3 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.2 | 0.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.5 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.2 | 1.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 2.1 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.2 | 0.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 0.3 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.9 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 1.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.9 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.3 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.4 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.4 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.1 | 1.6 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.3 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 3.7 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.6 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.3 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 2.0 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.6 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.1 | 0.6 | GO:0008207 | C21-steroid hormone metabolic process(GO:0008207) |
0.1 | 1.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.7 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.1 | 0.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.7 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.9 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 1.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 1.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.1 | GO:0042520 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.1 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.4 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.8 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 4.3 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 1.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.7 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 0.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.3 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 1.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.3 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 | 3.8 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.1 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.1 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.8 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.4 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.3 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 0.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.7 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.8 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.3 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.1 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 1.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 1.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) prevention of polyspermy(GO:0060468) |
0.1 | 0.6 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.1 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.5 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.1 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) regulation of metallopeptidase activity(GO:1905048) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.3 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.5 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.1 | 0.4 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.1 | 0.4 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.1 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.1 | 0.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.4 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
0.1 | 0.4 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.1 | 0.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.1 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
0.1 | 2.5 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.1 | 0.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.1 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.1 | 0.5 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.4 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.5 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.1 | 1.0 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 1.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.2 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.2 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.1 | 0.6 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 1.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.1 | GO:0034436 | glycoprotein transport(GO:0034436) very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 0.1 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.1 | 1.7 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.4 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.1 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.1 | 0.1 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.1 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.3 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.1 | 0.5 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.7 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 1.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 5.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.3 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.7 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 1.9 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.5 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 1.0 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.9 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.2 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 1.2 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.4 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.2 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.1 | 0.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.2 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.1 | 0.1 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.1 | GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) |
0.1 | 0.3 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.1 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 1.8 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 1.0 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.5 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.1 | 1.0 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 7.3 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.1 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 0.3 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 0.3 | GO:0098763 | mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.4 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 1.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.7 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.6 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.4 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 1.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.1 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 1.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 1.9 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.2 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.1 | GO:0003094 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
0.1 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) |
0.1 | 0.4 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.1 | 0.4 | GO:0060897 | neural plate regionalization(GO:0060897) |
0.1 | 0.4 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.5 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 1.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.8 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.1 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.5 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.1 | 0.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.2 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.2 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.7 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.5 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) female meiosis chromosome segregation(GO:0016321) |
0.1 | 0.3 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.6 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.3 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.3 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) |
0.1 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.9 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 1.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 2.3 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.1 | 0.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.4 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.3 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.6 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 1.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.3 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.1 | 0.1 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.1 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 2.7 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.1 | 0.1 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.1 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.1 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 0.5 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.1 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.1 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.2 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.1 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 1.6 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.5 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 1.1 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.5 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.3 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.6 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.6 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.1 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 1.3 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.2 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 3.4 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.1 | 0.8 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.1 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.1 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.3 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.2 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.2 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 0.1 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.1 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.1 | 1.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.4 | GO:0075733 | intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.1 | 0.1 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.2 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.3 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 1.9 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.4 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.1 | 0.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.7 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.2 | GO:0035990 | tendon development(GO:0035989) tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.2 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.2 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 0.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.3 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.1 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.2 | GO:0042761 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.3 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.1 | 0.3 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.4 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.1 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.1 | 0.1 | GO:0035768 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.1 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.1 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.1 | 0.3 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.1 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.1 | 0.1 | GO:0070944 | neutrophil mediated killing of bacterium(GO:0070944) |
0.1 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 1.1 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.3 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.2 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.8 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 1.5 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 0.2 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.1 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.1 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 0.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.1 | GO:0033628 | regulation of cell adhesion mediated by integrin(GO:0033628) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.1 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.1 | 0.2 | GO:0051350 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of lyase activity(GO:0051350) |
0.1 | 0.4 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.1 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.1 | 2.1 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 0.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.1 | GO:0099518 | vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 0.3 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.8 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.4 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 1.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.1 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.1 | 0.1 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.1 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.1 | 0.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.2 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of leukocyte apoptotic process(GO:2000108) |
0.1 | 1.5 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.1 | 2.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.1 | 0.3 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.2 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.1 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.3 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.5 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.4 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.3 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.1 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 0.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.0 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 3.2 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.7 | GO:0042308 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.1 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.2 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.0 | 0.1 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.1 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.0 | 0.2 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.0 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 1.3 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.0 | 0.5 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 1.4 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.2 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.0 | GO:0061511 | centriole elongation(GO:0061511) |
0.0 | 0.2 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 1.5 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.0 | 0.3 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.0 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.0 | GO:0060136 | negative regulation of icosanoid secretion(GO:0032304) embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 6.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.0 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) positive regulation of killing of cells of other organism(GO:0051712) |
0.0 | 0.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.2 | GO:0001825 | blastocyst formation(GO:0001825) |
0.0 | 1.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.1 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.1 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.4 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.0 | 0.1 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.0 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.0 | 0.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.0 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.0 | 0.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0060544 | regulation of necroptotic process(GO:0060544) |
0.0 | 0.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 1.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.3 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.0 | 0.1 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.0 | 0.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.0 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.0 | 0.0 | GO:0034165 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.1 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 0.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.0 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.0 | 0.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0032355 | response to estradiol(GO:0032355) |
0.0 | 0.0 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.1 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.0 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.0 | 0.2 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.0 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.4 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.0 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.1 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.0 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 0.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.0 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.0 | 0.1 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.0 | 0.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.0 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.1 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.0 | 0.1 | GO:0042755 | eating behavior(GO:0042755) |
0.0 | 0.0 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.0 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.0 | 0.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.1 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.0 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0072177 | mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
0.0 | 0.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.0 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.0 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.3 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.3 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.0 | 0.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.1 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.0 | GO:0051383 | kinetochore organization(GO:0051383) |
0.0 | 0.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.0 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.0 | 0.0 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.0 | 0.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.0 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.0 | 0.1 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.0 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.0 | 0.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.0 | GO:0071312 | cellular response to alkaloid(GO:0071312) |
0.0 | 0.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.1 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 0.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 0.0 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.0 | 0.0 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.0 | 0.0 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.0 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.2 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.0 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.0 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.0 | 0.1 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.2 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.0 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.0 | 0.0 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:0002347 | response to tumor cell(GO:0002347) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 14.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
2.0 | 14.2 | GO:0030056 | hemidesmosome(GO:0030056) |
1.7 | 3.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.6 | 9.3 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.5 | 4.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.4 | 2.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.3 | 5.2 | GO:1990357 | terminal web(GO:1990357) |
1.3 | 3.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.2 | 2.5 | GO:0005914 | spot adherens junction(GO:0005914) |
1.2 | 3.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.2 | 2.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.1 | 19.5 | GO:0043034 | costamere(GO:0043034) |
1.1 | 1.1 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.1 | 3.2 | GO:0097513 | myosin II filament(GO:0097513) |
0.9 | 15.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.9 | 3.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.8 | 3.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.8 | 7.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.8 | 8.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.8 | 2.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.8 | 0.8 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.8 | 11.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.8 | 8.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.7 | 0.7 | GO:0030686 | 90S preribosome(GO:0030686) |
0.7 | 2.8 | GO:0030478 | actin cap(GO:0030478) |
0.7 | 4.9 | GO:0090543 | Flemming body(GO:0090543) |
0.7 | 1.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.7 | 2.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.7 | 2.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 5.2 | GO:0005861 | troponin complex(GO:0005861) |
0.6 | 2.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.6 | 8.0 | GO:0005605 | basal lamina(GO:0005605) |
0.6 | 1.8 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.6 | 0.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.6 | 2.5 | GO:0071203 | WASH complex(GO:0071203) |
0.6 | 5.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.6 | 3.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 1.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.6 | 2.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 6.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.5 | 1.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.5 | 1.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.5 | 2.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.5 | 6.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.5 | 3.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 20.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.5 | 3.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.5 | 25.2 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.5 | 1.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 3.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 3.4 | GO:0045180 | basal cortex(GO:0045180) |
0.5 | 1.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 1.4 | GO:0031523 | Myb complex(GO:0031523) |
0.5 | 3.3 | GO:0045179 | apical cortex(GO:0045179) |
0.5 | 1.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.5 | 0.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.5 | 1.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 2.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.5 | 0.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.4 | 1.3 | GO:0005767 | secondary lysosome(GO:0005767) |
0.4 | 1.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 1.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 17.7 | GO:0045095 | keratin filament(GO:0045095) |
0.4 | 1.3 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 1.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 1.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 1.6 | GO:0000938 | GARP complex(GO:0000938) |
0.4 | 3.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 3.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.4 | 0.8 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.4 | 11.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.4 | 5.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 4.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.4 | 2.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 9.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.4 | 2.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 0.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.4 | 1.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 3.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 3.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 1.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 4.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.4 | 5.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 3.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 1.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 1.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 1.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 1.1 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 1.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.3 | 1.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 2.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 1.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 6.0 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 2.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.3 | 1.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 1.0 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 1.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.3 | 2.9 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.3 | 1.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 0.6 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 0.6 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 2.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 4.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 0.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 2.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 6.8 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.3 | 1.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 7.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 1.2 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 2.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.8 | GO:1990462 | omegasome(GO:1990462) |
0.3 | 2.7 | GO:0002102 | podosome(GO:0002102) |
0.3 | 1.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 0.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 3.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 2.7 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 1.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 0.6 | GO:0032432 | actin filament bundle(GO:0032432) |
0.3 | 2.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.3 | 1.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 0.8 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 2.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 0.8 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.3 | 67.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.3 | 1.3 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 0.5 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.3 | 2.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 1.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 18.0 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.3 | 1.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 0.8 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 2.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 4.0 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 5.8 | GO:0031672 | A band(GO:0031672) |
0.3 | 0.8 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 1.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 1.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 1.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.7 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 3.2 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 14.9 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 1.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 0.7 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 3.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 9.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 1.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 4.4 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.2 | 2.3 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 1.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 0.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 1.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 1.6 | GO:0061702 | inflammasome complex(GO:0061702) |
0.2 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 1.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.9 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 1.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 1.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 0.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 0.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 1.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 8.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 0.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 8.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 17.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 0.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.2 | 8.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 2.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 17.3 | GO:0005903 | brush border(GO:0005903) |
0.2 | 0.6 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 2.2 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 2.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 0.6 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 9.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 1.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 0.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 0.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 10.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 0.2 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.2 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 3.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 1.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 8.9 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.9 | GO:1904949 | ATPase complex(GO:1904949) |
0.2 | 18.0 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.2 | 0.4 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 1.0 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 0.5 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 6.6 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 1.8 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 1.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 1.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 6.2 | GO:0031674 | I band(GO:0031674) |
0.2 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 3.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 5.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.2 | 10.1 | GO:0005882 | intermediate filament(GO:0005882) |
0.2 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 6.3 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 1.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.5 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 1.3 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 1.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 2.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 0.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 1.2 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 1.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 0.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 1.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 0.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 12.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 2.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 1.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 8.3 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.4 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.7 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 6.8 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.1 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 0.7 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 1.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 2.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 1.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 1.9 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 1.4 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.4 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.6 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.5 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 3.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 25.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 1.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.5 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 1.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 1.2 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 6.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 0.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 1.0 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.1 | GO:0044440 | endosomal part(GO:0044440) |
0.1 | 1.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 2.4 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 7.2 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 1.0 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 20.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.5 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 1.3 | GO:0043292 | contractile fiber(GO:0043292) |
0.1 | 0.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.2 | GO:0045240 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.3 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 2.5 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 3.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 2.1 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 3.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 1.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.8 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.3 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.6 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 3.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 1.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.2 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 1.9 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.6 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.4 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 5.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 0.7 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 1.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 1.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 1.0 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 5.8 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 2.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.6 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.1 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.5 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 8.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.6 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 13.1 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 1.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 1.5 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 2.8 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 1.8 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 51.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 1.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 1.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 2.0 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.3 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.1 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 6.4 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 17.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.0 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 0.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.1 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.0 | 0.0 | GO:0030684 | preribosome(GO:0030684) |
0.0 | 0.1 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 9.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
2.7 | 8.0 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.5 | 19.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
2.1 | 8.2 | GO:0042731 | PH domain binding(GO:0042731) |
2.0 | 10.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.9 | 5.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.7 | 5.0 | GO:0048030 | disaccharide binding(GO:0048030) |
1.6 | 9.5 | GO:0038132 | neuregulin binding(GO:0038132) |
1.6 | 6.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.5 | 5.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.3 | 9.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.3 | 5.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.3 | 6.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.3 | 3.8 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.3 | 5.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.2 | 3.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.2 | 3.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.1 | 3.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.1 | 8.0 | GO:0018647 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.1 | 1.1 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.1 | 4.3 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.1 | 4.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.0 | 5.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.0 | 10.4 | GO:0044548 | S100 protein binding(GO:0044548) |
1.0 | 3.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.0 | 3.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.0 | 3.0 | GO:0030172 | troponin C binding(GO:0030172) |
1.0 | 7.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.0 | 6.0 | GO:0052630 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
1.0 | 4.0 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.0 | 2.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.0 | 1.0 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
1.0 | 4.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.9 | 2.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.9 | 13.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.9 | 1.8 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.9 | 2.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.9 | 0.9 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.9 | 0.9 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.9 | 7.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.9 | 20.2 | GO:0042805 | actinin binding(GO:0042805) |
0.9 | 3.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.9 | 2.6 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.9 | 3.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.8 | 3.3 | GO:0045340 | mercury ion binding(GO:0045340) |
0.8 | 2.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.8 | 2.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.8 | 4.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.8 | 8.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.8 | 3.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.8 | 3.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.8 | 3.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.8 | 4.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.8 | 3.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.8 | 2.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.7 | 3.7 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.7 | 3.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.7 | 0.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.7 | 1.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.7 | 2.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.7 | 1.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.7 | 2.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.7 | 2.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.7 | 1.4 | GO:0015928 | fucosidase activity(GO:0015928) |
0.7 | 0.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.7 | 2.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.7 | 5.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 3.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.7 | 3.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 4.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.7 | 4.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.7 | 2.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.7 | 11.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.7 | 2.0 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.7 | 2.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.6 | 2.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.6 | 2.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.6 | 2.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.6 | 1.9 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.6 | 7.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.6 | 2.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.6 | 2.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.6 | 6.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 0.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.6 | 8.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 1.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.6 | 4.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.6 | 2.9 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.6 | 1.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.6 | 4.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 2.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.6 | 1.7 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.6 | 0.6 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
0.6 | 1.7 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.6 | 2.8 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.6 | 1.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.6 | 0.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.5 | 2.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 2.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.5 | 1.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.5 | 5.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 0.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 6.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 6.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.5 | 2.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.5 | 2.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.5 | 1.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 2.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 1.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.5 | 2.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.5 | 2.5 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 1.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 11.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.5 | 4.0 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.5 | 2.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.5 | 2.0 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.5 | 7.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 5.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.5 | 6.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 1.4 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.5 | 1.9 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.5 | 1.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 1.4 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.5 | 1.4 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.5 | 1.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.5 | 0.5 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.5 | 1.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.5 | 0.5 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.5 | 1.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 3.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.5 | 1.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.5 | 1.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.5 | 4.6 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.5 | 3.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.5 | 0.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.5 | 15.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.5 | 1.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 1.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 1.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 0.5 | GO:0035276 | ethanol binding(GO:0035276) |
0.5 | 1.8 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.4 | 3.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 1.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.4 | 2.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.4 | 1.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 0.4 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.4 | 2.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 3.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 1.3 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.4 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 1.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.4 | 8.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 7.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 1.7 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.4 | 8.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 1.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.4 | 2.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 1.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 2.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.4 | 1.7 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 2.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 3.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 6.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.4 | 4.1 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.4 | 1.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.4 | 1.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 4.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 7.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.4 | 5.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 5.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.4 | 0.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.4 | 1.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 2.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 0.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.4 | 2.0 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 0.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 1.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 1.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 4.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.4 | 7.5 | GO:0043236 | laminin binding(GO:0043236) |
0.4 | 0.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.4 | 1.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.4 | 1.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 0.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 1.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.4 | 10.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.4 | 1.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 0.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.4 | 1.1 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 0.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 0.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.4 | 1.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.4 | 1.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 2.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 0.7 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.4 | 5.8 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 0.7 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.4 | 1.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.4 | 1.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 1.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 1.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 1.1 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 1.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.4 | 1.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 2.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 1.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 6.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 0.7 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 2.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.3 | 1.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 1.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 3.7 | GO:0004787 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.3 | 0.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.3 | 1.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 1.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 1.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 3.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 3.7 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.3 | 1.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 0.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 1.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 3.3 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 1.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 4.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 0.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.3 | 3.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 0.3 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.3 | 2.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 2.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.3 | 2.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 3.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 2.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.3 | 2.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 4.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 3.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.3 | 1.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 1.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 1.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 1.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 0.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 1.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 0.9 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.3 | 1.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 1.5 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.3 | 6.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 0.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 1.8 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.3 | 0.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 1.5 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.3 | 1.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 0.9 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 0.9 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 2.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 1.2 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 0.6 | GO:0032767 | copper chaperone activity(GO:0016531) copper-dependent protein binding(GO:0032767) |
0.3 | 0.6 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 0.9 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 0.9 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 1.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 5.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 0.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 3.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 0.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 1.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.3 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 1.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 3.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 1.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 6.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 1.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 0.3 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.3 | 4.9 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.3 | 1.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 13.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 1.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 0.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.3 | 1.1 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.3 | 0.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 1.8 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 3.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.3 | 2.6 | GO:0008061 | chitin binding(GO:0008061) |
0.3 | 1.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.3 | 1.3 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.3 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 1.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 1.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 0.3 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.3 | 4.0 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 1.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 0.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 0.5 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.2 | 1.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 3.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 13.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 1.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.5 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 0.7 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.5 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 1.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 0.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 1.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.7 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 3.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 1.6 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 2.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.7 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.9 | GO:0035671 | enone reductase activity(GO:0035671) |
0.2 | 6.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 1.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.9 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 2.0 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 3.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 2.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.2 | 0.2 | GO:0015927 | trehalase activity(GO:0015927) |
0.2 | 0.2 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.2 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 2.8 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 0.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 1.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 0.2 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.2 | 1.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 6.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 1.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 0.4 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 1.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 0.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 1.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 3.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 6.0 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 0.6 | GO:0043121 | neurotrophin binding(GO:0043121) brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 1.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 1.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 1.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 1.0 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 0.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 1.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 3.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.6 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.4 | GO:0035877 | death effector domain binding(GO:0035877) |
0.2 | 0.9 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 2.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 3.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 1.7 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 1.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 1.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 0.2 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.2 | 0.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 3.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.5 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 1.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 1.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.2 | GO:0034580 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.2 | 0.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 5.5 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 1.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 2.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.4 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.2 | 0.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 2.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.2 | 0.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 0.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 8.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 1.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 1.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 2.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 0.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 2.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 1.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 5.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 0.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 0.7 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 1.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.5 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 1.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 3.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 1.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.7 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 1.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 4.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 0.8 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 0.6 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 1.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 0.3 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.2 | 1.1 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 0.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 0.2 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.2 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 1.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 1.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 0.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.3 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 0.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 0.3 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.2 | 0.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 0.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.2 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.2 | 5.4 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.8 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 0.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 3.8 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.2 | 1.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 2.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 0.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.9 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 1.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 0.8 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 1.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.4 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 1.0 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 2.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.9 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 1.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 1.0 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.1 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 1.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 3.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 1.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 1.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 2.8 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 13.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 3.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 1.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 1.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 2.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.1 | GO:0032557 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 1.4 | GO:0019955 | cytokine binding(GO:0019955) |
0.1 | 2.0 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 5.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 2.0 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.1 | 0.3 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 5.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.6 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 5.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 1.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.1 | GO:0060590 | ATPase activator activity(GO:0001671) ATPase regulator activity(GO:0060590) |
0.1 | 0.4 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 1.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.4 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 0.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 1.1 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 9.0 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 12.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.6 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 1.3 | GO:0043909 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 1.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 1.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 1.3 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.7 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 27.3 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.6 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 4.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.2 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.3 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 2.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.8 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 2.5 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.7 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 3.6 | GO:0015085 | calcium ion transmembrane transporter activity(GO:0015085) |
0.1 | 1.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 1.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.6 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.5 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.6 | GO:0034778 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.7 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 2.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.2 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 2.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.3 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 1.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 3.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 1.6 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 1.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 29.5 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 1.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.1 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 2.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 6.6 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.2 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.6 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.5 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 1.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 2.9 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 2.5 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 1.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.9 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.1 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.1 | 2.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 1.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 6.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.1 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
0.1 | 0.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.1 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.1 | 0.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.2 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.6 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.2 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.5 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 4.0 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 3.1 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 15.5 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.3 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 0.2 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.1 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 1.4 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 3.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 5.4 | GO:0005543 | phospholipid binding(GO:0005543) |
0.1 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.1 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 3.4 | GO:0005253 | anion channel activity(GO:0005253) |
0.1 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 18.3 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.2 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.3 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.1 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 1.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 4.0 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.5 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.0 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.2 | GO:0016454 | C-palmitoyltransferase activity(GO:0016454) |
0.0 | 7.4 | GO:0008134 | transcription factor binding(GO:0008134) |
0.0 | 0.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 1.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.2 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 1.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.3 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 5.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.2 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.0 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.0 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.0 | 0.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.3 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 2.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.7 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.5 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.6 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.0 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.0 | 0.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 4.0 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.0 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 2.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 1.3 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 1.3 | GO:0008194 | UDP-glycosyltransferase activity(GO:0008194) |
0.0 | 0.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 3.2 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.0 | GO:0015108 | chloride transmembrane transporter activity(GO:0015108) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.0 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.1 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.0 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.0 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 0.5 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 25.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.3 | 2.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.0 | 11.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.8 | 0.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.8 | 12.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.7 | 0.7 | PID MYC PATHWAY | C-MYC pathway |
0.7 | 17.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.7 | 19.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.6 | 9.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 16.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.5 | 11.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.5 | 24.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.5 | 2.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 10.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 12.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.5 | 7.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.5 | 5.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.5 | 3.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.5 | 9.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 3.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 1.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 9.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 6.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.4 | 17.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 7.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 1.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.4 | 3.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 1.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 0.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.4 | 4.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.4 | 9.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 13.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 2.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 1.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 8.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 7.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 2.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 2.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 1.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 6.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 11.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 8.6 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 17.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 4.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 3.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 4.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 12.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 6.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 2.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 1.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 3.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 4.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 11.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 0.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 1.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 3.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 2.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 2.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 0.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 1.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 1.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 10.5 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 3.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 5.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 3.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 7.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 2.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 2.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 1.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 1.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 1.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 4.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 1.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 7.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 0.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 1.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 1.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 3.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 0.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 2.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 6.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 1.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 1.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 3.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 1.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 0.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 1.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 9.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 23.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 0.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 0.4 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 0.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 0.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 5.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 1.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 1.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 1.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 3.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 20.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 4.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 3.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 0.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 1.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.6 | PID ATM PATHWAY | ATM pathway |
0.1 | 2.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 2.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 2.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 2.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 3.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 20.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 15.1 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 0.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.0 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 2.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.2 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.9 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 2.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.5 | 14.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.5 | 1.5 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.9 | 13.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.8 | 10.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.8 | 7.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.7 | 8.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.7 | 1.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.7 | 9.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.7 | 1.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.7 | 0.7 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.7 | 15.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.7 | 12.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.7 | 4.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.6 | 14.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.6 | 0.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.6 | 0.6 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.6 | 5.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.6 | 14.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 6.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.6 | 5.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.6 | 8.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 4.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 1.6 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.5 | 8.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 11.2 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.5 | 5.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 5.5 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.5 | 25.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 10.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.5 | 18.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.5 | 5.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 4.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 4.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 3.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.4 | 5.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 5.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 2.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 4.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 1.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.4 | 2.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 3.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 1.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 4.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 4.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 1.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 0.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 3.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 4.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 2.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 4.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 0.3 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.3 | 5.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 8.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.3 | 2.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 1.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.3 | 2.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 0.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 10.9 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.3 | 4.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 6.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 3.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 2.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 0.6 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 1.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 1.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 4.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 0.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 2.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 1.4 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.3 | 4.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.3 | 2.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 0.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 2.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 0.8 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.3 | 1.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 6.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 0.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 3.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 2.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 3.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 3.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 3.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.3 | 1.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.3 | 10.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 7.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 3.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 3.8 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 2.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 2.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 3.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 3.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 2.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 2.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 2.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 3.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 3.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 3.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 0.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 1.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 6.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 10.4 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 0.6 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.2 | 3.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 2.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 6.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 2.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 0.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 2.8 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 3.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 1.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 1.6 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 1.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 1.8 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 2.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 0.3 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.2 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 2.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 0.6 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.2 | 1.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 2.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 4.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 1.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 5.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 6.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 18.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 0.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 3.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 4.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 1.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.9 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.1 | 0.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 1.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.7 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 2.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 2.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 2.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 1.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 2.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 0.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 4.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 2.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 7.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 3.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 2.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.1 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.1 | 2.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 2.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.3 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.1 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 3.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 4.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.7 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 2.9 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.6 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.0 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.0 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.0 | 0.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.1 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |